Neuronetics STIM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 48%-15.6pp | 48.5%-23.8pp | 50.4%-25.3pp | 56.2%-17.1pp | 63.5%-9.4pp | |
| Operating margin | -19.4%+23.9pp | -21.1%+25.1pp | -29.2%+8.7pp | -34.4%+5.3pp | -43.3%-5.7pp | |
| Net margin | -24.5%+29.8pp | -26.1%+32.2pp | -34.3%+15.8pp | -43.9%+1.1pp | -54.2%-16.6pp | |
| EBITDA margin | -17.2%+23.4pp | -18.8%+24.6pp | -26.7%+8.2pp | -32%+4.9pp | -40.6%-5.8pp | |
| Free cash flow margin | -9.4%+32.3pp | -14.7%+28.7pp | -23.5%+9.2pp | -31.9%+7.8pp | -41.7%+2.8pp | |
| Returns | ||||||
| Return on equity | -152.4%+1.4pp | -155.7%-14.5pp | -242.3%-88.3pp | -209.7%-110pp | -153.7%-81.3pp | |
| Return on assets | -27.8%+11.7pp | -27.6%+6.4pp | -40.5%+3.1pp | -42.2%-9.2pp | -39.5%-12.9pp | |
| Return on invested capital | -32.1%+23.1pp | -35.6%+18.0pp | -59.5%+9.8pp | -56.2%+16.2pp | -55.3%+17.5pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.4× | 1.1×+0.5× | 1.2×+0.3× | 1×+0.2× | 0.7×0.0× | |
| Inventory turnover | 18×+11.9× | 17.9×+14.6× | 13.9×+11.5× | 8.8×+6.2× | 6.1×+3.6× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.8× | 2×+0.2× | 2.2×-0.9× | 2×-0.6× | 2.4×-3.2× | |
| Quick ratio | 1.5×-0.8× | 1.9×+0.2× | 2.1×-0.8× | 1.8×-0.5× | 2.3×-2.9× | |
| Cash ratio | 0.5×-0.3× | 0.9×+0.3× | 1×-0.3× | 0.4×-1.1× | 0.8×-2.5× | |
| Leverage | ||||||
| Debt-to-equity | 6.4×+4.1× | 4×+1.1× | 3.3×-1.9× | 3×-0.3× | 2.3×+0.1× | |
| Debt-to-assets | 0.7×+0.1× | 0.6×+0.1× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Interest coverage | -3.4×+1.9× | -3.7×+1.0× | -4.8×-1.1× | -5.2×-1.0× | -5.2×-0.7× | |
| Per Share | ||||||
| Book value per share | $0.19-67.0% | $0.34-61.1% | $0.41+31.1% | $0.41-36.4% | $0.58-38.5% | |
| Valuation | ||||||
| Market capitalization | $90.46M-56.2% | $94.51M+5.5% | $180.52M+691% | $233M+339% | $238.76M+70.2% | |
| Enterprise value | $162.64M-42.0% | $156.68M+1.9% | $243.3M+380% | $302.69M+314% | $301.07M+94.2% | |
| Price / sales | 0.6×-1.3× | 0.6×-0.6× | 1.4×+1.1× | 2.1×+1.4× | 2.7×+0.8× | |
| Price / book | 7.4×-0.8× | 4.2×+1.0× | 6.6×+4.2× | 8.6×+5.8× | 6.7×+1.7× | |
| EV / sales | 1.1×-1.5× | 1.1×-1.0× | 1.9×+1.2× | 2.7×+1.7× | 3.4×+1.2× | |
| Free cash flow yield | -14.5%+1.3pp | -23.1%+13.1pp | -16.9%+87.2pp | -15.2%+38.8pp | -15.6%+7.6pp | |
| Earnings yield | -37.8%-16.0pp | -41.3%+7.5pp | -24.7%+135pp | -20.9%+40.3pp | -20.3%-0.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuronetics's profit margins?
- Neuronetics (STIM) runs a 48.0% gross margin and a -19.4% operating margin, with a -24.5% net margin.
- Where do Neuronetics's ratios come from?
- Every ratio is computed from Neuronetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
